• AAPL 169.89
  • TSLA 170.18
  • AMZN 173.67
  • MSFT 399.04
  • INTC 35.11
  • EURUSD 1.0731
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. HM /
  3. BAYN.HM

Bayer AG NA (BAYN HM) stock market data APIs

€26.9 -0.03(-0.1%) as of April 25, 2024

Bayer AG NA Financial Data Overview

26.925
26.9
-
27.395
26.9
24.995-58.49
45 791 M
0
0
1.22
0.0497
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BAYN',
Type: 'Common Stock',
Name: 'Bayer AG NA',
Exchange: 'HM',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Other',
Industry: 'Other',
}

Bayer AG NA Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Bayer AG NA Earnings via APIs

  • Latest Release 2023-08-08
  • EPS/Forecast 1.26

Get Bayer AG NA End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Bayer AG NA latest news via APIs

Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales

Swiss pharma giant Roche Holding AG’s RHHBY first-quarter 2024 revenues declined 6 % to CHF 14.4 billion due to the appreciation of the Swiss franc against most currencies and lower COVID-19-related...

Pharmaceutical giant Bayer’s manager cull will likely affect thousands of bosses—and the aspirin inventor thinks it will help its ‘brilliant’ Gen Z grads to thrive

In a bid to claw back $2.15 billion in costs, the chief executive of struggling pharmaceutical giant Bayer announced in early April that the company was eliminating middle managers and allowing nearly...
Do you have any questions?
support@eodhistoricaldata.com